Skip to main content

GW&K Investment Management, LLC

Position in CRNX — Crinetics Pharmaceuticals, Inc.

CIK 1082917 BOSTON, MA

Position in CRNX

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$58,790,674
-$9,932,254 QoQ
Shares Held
1,618,686
+9.6% QoQ
Ownership
1.54%
of shares outstanding
% of Portfolio
0.53%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2023
13 quarters on record
Voting authority Sole 95.32898906891145.ToString("F0")% Shared 4.638082988300387.ToString("F0")% None 0.032927942788162745.ToString("F0")%

Common Shares in CRNX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

GW&K Investment Management, LLC holds $699,704,251 across 25 Biotechnology names. CRNX ranks #5 (8.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 CRNX
Crinetics Pharmaceuticals, Inc.
This page
1,618,686 $58,790,674

All Filings in CRNX

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $58,790,674 1,618,686
2025-12-31 $68,722,928 1,476,325
2025-09-30 $35,425,240 850,546
2025-06-30 $27,920,494 970,810
2025-03-31 $30,857,470 920,020
2024-12-31 $34,723,558 679,123
2024-09-30 $37,450,781 732,892
2024-06-30 $16,915,525 377,663
2024-03-31 $18,165,369 388,066
2023-12-31 $17,045,061 479,063
2023-09-30 $14,362,695 482,942
2023-06-30 $10,555,034 585,740
2023-03-31 $8,622,292 536,880